AAPP 2027 Annual Meeting: Program & Speakers
24 sessions across 4 days with 32 confirmed speakers — the program for AAPP 2027 Annual Meeting, April 4–7, 2027 in Louisville, KY. From the official program; excludes exhibits and social events.
Featured speakers: Jeffrey R. Bishop · Randye Kaye · Ambrose Wong · JoAn R. Laes · Robert "Cole" Pueringer · Dana Chiulli · Richard Silvia · Caitlin McCoyd · Lacey J. Vann · Bob Haight · Amy Werremeyer · Austin Campbell · and 20 more below
No sessions match those filters. — or browse the full official program.
April 4, 2027
- 12:15–13:15LectureThe Cycle of Chaos to Hope: Navigating Schizophrenia as a Mother and Caregiver
A keynote by a mother and advocate describing her family's experience with a son's schizophrenia, and how psychiatric pharmacists can partner with family caregivers to build trust, improve communication and support recovery.
Collaborative & Integrated CareSchizophrenia & PsychosisSerious Mental Illness
- 13:20–14:20LectureClinical Application SeriesGas Station Drugs and Emerging Illicit Substances
JoAn R. Laes · Robert "Cole" Pueringer
Online course on psychoactive products sold at gas stations, convenience stores and online with little oversight. Covers their pharmacology, dependence and withdrawal risks, psychiatric adverse effects, and how to apply this to patient counseling and treatment planning.
Cannabis & CannabinoidsDrug Interactions & SafetySubstance Use Disorders
- 14:40–15:40DebateChoices, Choices: A Debate on Antipsychotic Polypharmacy Care Decisions
Bob Haight · Amy Werremeyer · Austin Campbell
A debate-format session on contentious antipsychotic decisions where guidelines give limited direction, including polypharmacy versus clozapine monotherapy, choosing among long-acting injectables, and handling inadequate response to LAIs.
Antipsychotic PrescribingClozapineDeprescribing & PolypharmacyLong-Acting Injectables
April 5, 2027
- 08:00–09:00LectureClinical Application SeriesMental Health Care in Oncology: Highlighting a Lived Experience
A session drawing on a patient's lived experience and current evidence to examine anxiety, depression and distress in people with cancer. It covers barriers to integrated mental health care and the psychiatric pharmacist's role in supporting patients, including menopause related to cancer treatment.
Anxiety DisordersCollaborative & Integrated CareDepressionMedical Comorbidity & C-L Psychiatry
- 09:15–10:15LectureWhen Panic Persists: Navigating Difficult to Treat Panic Disorder
Reviews pharmacologic and nonpharmacologic options for panic disorder that persists after first-line treatment, including emerging strategies and how to apply evidence to complex cases. Covers monitoring treatment response and safety.
Anxiety DisordersPharmacogenomics & Precision PsychiatryTreatment-Resistant Depression
- 12:20–13:20LectureClinical Application SeriesMedication Strategies for Behavioral and Psychological Symptoms of Dementia
Reviews how behavioral and psychological symptoms of dementia present and weighs the evidence, benefits and risks of current and newly approved medications, including for Parkinson disease psychosis. Focuses on building individualized treatment plans.
Antipsychotic PrescribingDementia & Cognitive DisordersGeriatric
- 12:20–13:20LectureClinical Application SeriesImproving Psychotropic Prescribing in Foster Care: The Essential Role of the BCPP
Looks at why youth in foster care often receive complex psychotropic regimens and how board-certified psychiatric pharmacists can support safer prescribing. Covers stewardship approaches, barriers to including pharmacists on foster care teams, and state advocacy efforts.
Child & AdolescentCollaborative & Integrated CareDeprescribing & PolypharmacyPractice, Policy & Workforce
- 13:30–14:30LectureClinical Application SeriesMastering Mood Stabilizers: Navigating Interactions and Adverse Effects
An online course on safe use of mood stabilizers, covering clinically important drug interactions, adverse effects, monitoring plans, and patient-centered counseling to support adherence and shared decision-making.
Bipolar DisorderDrug Interactions & SafetyLithium & Mood Stabilizers
- 13:30–14:30LectureMember-Submitted ProgramNavigating Difficult Conversations in Psychiatric Pharmacy: Practical Strategies for Learners, Preceptors, and Leaders
An online course on preparing for and handling high-stakes conversations with patients, learners, and colleagues in psychiatric pharmacy practice. It covers separating facts from assumptions, building psychological safety, and using structured communication techniques.
- 14:50–15:50LectureMember-Submitted ProgramAntipsychotic Pharmacogenomics: Consensus Guideline Updates and Clinical Application
Reviews current consensus guidelines on pharmacogenomic testing for antipsychotic therapy, key gene-drug interactions, and which patients may benefit most. Uses real-world clinical scenarios to show how to apply results to treatment decisions.
Antipsychotic PrescribingPharmacogenomics & Precision PsychiatrySchizophrenia & Psychosis
- 14:50–15:50LectureClinical Application SeriesNeuropsychiatric Comorbidities of Multiple Sclerosis
Covers how common psychiatric symptoms present in people with multiple sclerosis and reviews the safety and efficacy of pharmacologic options given limited evidence. Focuses on choosing individualized treatment regimens for co-occurring psychiatric symptoms.
Drug Interactions & SafetyMedical Comorbidity & C-L Psychiatry
April 6, 2027
- 08:00–09:00LectureAdvancing Equity in Acute Agitation Management
Online course on disparities in the pharmacologic management of acute agitation across inpatient psychiatric and emergency settings. Covers how structural factors and implicit bias affect prescribing and the pharmacist's role in standardizing protocols and promoting equitable care.
Drug Interactions & SafetyEmergency & Acute PsychiatryDiverse & Underserved Populations
- 08:00–09:00SymposiumMeasurement-Based Care: From Scores to Action (AUDIT-C and PCL-5)
Dana Chiulli · Richard Silvia · Caitlin McCoyd · Lacey J. Vann
A small-group, case-based workshop on interpreting AUDIT-C and PCL-5 scores and using them to guide treatment and follow-up decisions. Participants practice tracking score changes over time with facilitator feedback.
Alcohol Use DisorderEducation & TrainingMeasurement-Based Care & DiagnosisPTSD & Trauma
- 09:15–10:15LectureClinical Application SeriesPsychosis in the Context of Substance Use: Primary Diagnosis or Substance Effect?
Aaron Salwan · Abraham Thengampallil
Online course on telling substance-induced psychosis apart from a primary psychotic disorder. Covers substances linked to psychosis, treatment approaches including antipsychotic management, and the psychiatric pharmacist's role.
Antipsychotic PrescribingMeasurement-Based Care & DiagnosisSchizophrenia & PsychosisSubstance Use Disorders
- 09:15–10:15SymposiumClinical Application SeriesMeasurement-Based Care: From Scores to Action (PHQ-9 and GAD-7)
Dana Chiulli · Richard Silvia · Caitlin McCoyd · Lacey J. Vann
A small-group, case-based workshop on interpreting PHQ-9 and GAD-7 scores and using them to guide treatment and follow-up decisions. Participants practice tracking score changes over time with facilitator feedback. In-person only and not recorded.
Anxiety DisordersDepressionMeasurement-Based Care & Diagnosis
- 12:20–13:20LectureClinical Application SeriesManaging Psychiatric Symptoms in Neurogenetic Syndromes
Reviews psychiatric and behavioral symptoms seen in neurogenetic syndromes and the evidence for pharmacologic treatment, including emerging options. Covers safety, ethical considerations and building patient-centered, stewardship-oriented treatment plans.
Autism & Neurodevelopmental DisordersChild & AdolescentPharmacogenomics & Precision PsychiatryMedical Comorbidity & C-L Psychiatry
- 12:20–13:20CourseClinical Pearls
Online continuing education course from the AAPP 2027 meeting for pharmacists, nurse practitioners and other clinicians involved in medication management for people with mental health and substance use disorders. Content is based on Clinical Pearls submissions, and the page notes that learning objectives are still to come.
- 13:30–14:30LectureClinical Application SeriesAntiseizure Medications in Neuropsychiatric Practice: Identifying, Preventing, and Managing Adverse Effects
Online course on the systemic and neuropsychiatric adverse effects of antiseizure medications, covering patient-specific risk factors and strategies to prevent, identify and manage problems. Emphasizes individualized treatment plans to improve safety and adherence.
Drug Interactions & SafetyLithium & Mood StabilizersMedical Comorbidity & C-L Psychiatry
- 13:30–14:30LectureMember-Submitted ProgramAI-Induced Psychosis: Are We There Yet?
Examines reported cases where interactions with AI chatbots were linked to onset or worsening of psychosis, including the evidence, legal and ethical implications, and the role of LLM guardrails in reducing risk.
Digital Psychiatry & AIForensic & CorrectionalSchizophrenia & Psychosis
- 14:50–15:50LectureClinical Application SeriesLegal and Ethical Decision-Making in Involuntary Commitment
Covers the legal principles and ethical considerations involved in involuntary psychiatric treatment, and how to choose and manage pharmacotherapy for patients under commitment.
Emergency & Acute PsychiatryForensic & CorrectionalPractice, Policy & Workforce
- 14:50–15:50LectureTestosterone Across the Male Lifespan and Implications for Mental Health
Covers how testosterone changes across a man's life and how it relates to mood, anxiety and cognition. Reviews neurotransmitter mechanisms, patient selection for screening, and the benefits, limits and risks of testosterone replacement therapy.
Anxiety DisordersDepressionNeuroscience & MechanismsMedical Comorbidity & C-L Psychiatry
April 7, 2027
- 07:00–08:00LectureClinical Application SeriesPsychotropic Stewardship from Startup to Sustainability
Offers a practical, stepwise roadmap for building, launching and expanding a psychotropic stewardship program in different practice settings. Covers core program elements and strategies for growth based on resources, staffing and organizational priorities.
Collaborative & Integrated CareDeprescribing & PolypharmacyPractice, Policy & Workforce
- 08:00–09:00LectureMember-Submitted ProgramImplementation Science in Psychiatric Pharmacy
Clayton English · Jennifer Bacci
Introduces implementation science principles, frameworks and outcomes, and shows how they can help psychiatric pharmacists launch and sustain clinical services, stewardship efforts and educational innovations.
- 09:00–10:00LectureReal World/Practical Insights in New Medications
Liz Taber · David Dadiomov · Emily E. Leppien
Faculty share practical, experience-based guidance on using newer medications in clinical practice, covering zuranolone, buprenorphine and suzetrigine. The focus is on advantages, limitations and where each fits in care rather than on the underlying trial evidence.
Novel AntidepressantsOpioid Use DisorderPerinatal & Women's Mental HealthDrug Pipeline & Clinical Trials
Never miss an early-bird deadline
One-click alerts for this conference — we email you 14 and 3 days before each deadline:
- Conference starts — April 4, 2027
Browse the directory
By date
By specialty
- General Psychiatry
- Psychopharmacology
- Child & Adolescent Psychiatry
- Addiction Psychiatry
- Geriatric Psychiatry
- Forensic Psychiatry
- Consultation-Liaison Psychiatry
- Anxiety & Depression
- Neuroscience
- Psychiatric Nursing / PMHNP
- ADHD
- Bipolar Disorders
- Schizophrenia & Psychosis
- Trauma & PTSD
- Women's & Perinatal Mental Health
- Psychotherapy
- Emergency Psychiatry
- Interventional Psychiatry & Neuromodulation
- Psychedelic Medicine
- Suicide Prevention
- OCD & Related Disorders
- Autism Spectrum
- Sleep Medicine
By location
- International
- Midwest US
- Northeast US
- Southern US
- Western US
- California (6)
- Chicago (5)
- Illinois (5)
- San Diego (5)
- Colorado (4)
- Florida (4)
- Denver (3)
- Louisiana (3)
- New Orleans (3)
- New Zealand (3)
- Reston (3)
- Texas (3)
- Virginia (3)
- Austin (2)
- Australia (2)
- Hawaii (2)
- New York (2)
- Orlando (2)
- Washington (2)
- Washington, D.C. (2)
- Adelaide (1)
- Albuquerque (1)
- Arizona (1)
- Asheville (1)
- Atlanta (1)
- Auckland (1)
- Bahamas (1)
- Baltimore (1)
- Barcelona (1)
- Boston (1)
- Brazil (1)
- Canada (1)
- Cape Town (1)
- Cartagena (1)
- Christchurch (1)
- Cincinnati (1)
- Colombia (1)
- Colorado Springs (1)
- Dallas (1)
- Florence (1)
- France (1)
- Georgia (1)
- Glasgow (1)
- Italy (1)
- Kapolei (1)
- Kentucky (1)
- Koloa (Kauai) (1)
- Lake Buena Vista (1)
- Las Vegas (1)
- Louisville (1)
- Lyon (1)
- Maryland (1)
- Massachusetts (1)
- Minneapolis (1)
- Minnesota (1)
- Montreal (1)
- Nashville (1)
- Nevada (1)
- New Mexico (1)
- North Carolina (1)
- Ohio (1)
- Paradise Island (1)
- Queenstown (1)
- Rio de Janeiro (1)
- San Francisco (1)
- Scottsdale (1)
- South Africa (1)
- Spain (1)
- Tennessee (1)
- Thredbo Village (1)
- United Kingdom (1)
By type
By audience
Speakers & topics
Recurring meetings
- All conference series
- AAAP Annual Meeting and Scientific Symposium
- AACAP Annual Meeting
- AADPRT Annual Meeting
- AAGP Annual Meeting
- AAPL Annual Meeting
- AAPP Annual Meeting
- AAS Annual Conference
- ACLP Annual Meeting
- ACNP Annual Meeting
- ADAA Annual Conference
- AGPA Connect
- AMERSA Annual National Conference
- ANPA Annual Meeting
- APA Annual Meeting
- APNA Annual Conference
- APNA Clinical Psychopharmacology Institute
- APSARD Annual Conference
- APsA National Meeting
- ASAM Annual Conference
- ASCP Annual Meeting
- ASKP3 Annual Conference
- Annual International Conference on ADHD
- Annual OCD Conference
- Best Practices for Mood Disorders
- CINP World Congress of Neuropsychopharmacology
- Child & Adolescent Psychopharmacology (MGH Psychiatry Academy)
- ECNP Congress
- European Congress of Psychiatry
- IEPA International Conference on Early Intervention in Mental Health
- INSAR Annual Meeting
- ISBD Annual Conference
- ISPN Annual Conference
- ISTSS Annual Meeting
- International Brain Stimulation Conference
- International Marcé Society Biennial Conference
- MGH Annual Conference on Psychedelics and Psychedelic Medicine
- MGH Annual Psychopharmacology Conference
- MasterPsych Child & Adolescent Psychiatry Conference
- MasterPsych Psychiatry Conference
- Mayo Clinic Psychiatry Clinical Updates
- Medical Psychiatry: Comprehensive Update Conference
- NEI Congress
- NPA National Psychopharmacology Update
- NPACE Napa: Mental Health & Women's Health Conference
- National Update on Behavioral Emergencies (NUBE)
- Postpartum Support International Annual Conference
- Psych Congress
- Psych Congress NP Institute
- Psychedelic Science
- RANZCP Congress
- RCPsych International Congress
- SBSM Annual Meeting (formerly American Psychosomatic Society Annual Meeting)
- SIRS Congress
- SLEEP Annual Meeting (APSS)
- SOBP Annual Meeting
- Substance Use Disorders: A Comprehensive Review and Update
- WFSBP World Congress of Biological Psychiatry
- World Congress of Psychiatry